Guangzao Life Sciences
Microalgae-based solutions for biopharmaceutical development and production.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Series A | |
| Total Funding | 000k | ||
Guangzao Life Sciences, also known as Photoalgae, is a biotechnology company focused on the research, development, and application of microalgae. The company leverages its expertise in algal biology to create solutions for various industries, including biopharmaceuticals, nutraceuticals, and sustainable materials.
The firm's core business involves utilizing microalgae as bio-factories for producing high-value compounds. This includes the development of recombinant proteins, antibodies, and other biologics for therapeutic use. By harnessing the photosynthetic capabilities of algae, the company aims to provide a cost-effective and scalable manufacturing platform. In addition to pharmaceuticals, Guangzao Life Sciences explores the use of algal biomass for nutritional supplements and biodegradable products.
The company serves clients in the pharmaceutical and biotechnology sectors, offering contract development and manufacturing (CDMO) services. Their business model revolves around collaborative research projects, technology licensing, and the production of specific algal-derived products for partners. By focusing on a niche yet versatile biological system, Guangzao Life Sciences operates in the growing market for sustainable and innovative biotechnological solutions.
Keywords: microalgae technology, biopharmaceuticals, algal biology, sustainable materials, contract development manufacturing organization, CDMO, recombinant proteins, biologics production, nutraceuticals, photosynthetic manufacturing, biotechnology, algal biomass, therapeutic compounds, protein expression, cell culture